238 related articles for article (PubMed ID: 15339986)
1. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
Kitching AR; Turner AL; Wilson GR; Edgtton KL; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2004 Sep; 15(9):2373-82. PubMed ID: 15339986
[TBL] [Abstract][Full Text] [Related]
2. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
[TBL] [Abstract][Full Text] [Related]
4. IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.
Kitching AR; Turner AL; Wilson GR; Semple T; Odobasic D; Timoshanko JR; O'Sullivan KM; Tipping PG; Takeda K; Akira S; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2023-33. PubMed ID: 15888563
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
Phoon RK; Kitching AR; Jones LK; Holdsworth SR
Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
[TBL] [Abstract][Full Text] [Related]
6. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
[TBL] [Abstract][Full Text] [Related]
7. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
Powrie F; Menon S; Coffman RL
Eur J Immunol; 1993 Nov; 23(11):3043-9. PubMed ID: 8223881
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis.
Timoshanko JR; Kitching AR; Semple TJ; Holdsworth SR; Tipping PG
J Am Soc Nephrol; 2005 Sep; 16(9):2646-56. PubMed ID: 16033860
[TBL] [Abstract][Full Text] [Related]
11. T cells in crescentic glomerulonephritis.
Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2006 May; 17(5):1253-63. PubMed ID: 16624930
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
Powrie F; Menon S; Coffman RL
Eur J Immunol; 1993 Sep; 23(9):2223-9. PubMed ID: 8370402
[TBL] [Abstract][Full Text] [Related]
13. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
14. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus.
Peterson JD; Karpus WJ; Clatch RJ; Miller SD
Eur J Immunol; 1993 Jan; 23(1):46-55. PubMed ID: 8419186
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice.
Kitching AR; Tipping PG; Mutch DA; Huang XR; Holdsworth SR
Kidney Int; 1998 Jan; 53(1):112-8. PubMed ID: 9453006
[TBL] [Abstract][Full Text] [Related]
16. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
[TBL] [Abstract][Full Text] [Related]
17. An IL-12-independent role for CD40-CD154 in mediating effector responses: studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity.
Ruth AJ; Kitching AR; Li M; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Immunol; 2004 Jul; 173(1):136-44. PubMed ID: 15210767
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis.
Kitching AR; Holdsworth SR; Tipping PG
J Am Soc Nephrol; 1999 Apr; 10(4):752-9. PubMed ID: 10203359
[TBL] [Abstract][Full Text] [Related]
19. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis.
Timoshanko JR; Kitching AR; Semple TJ; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2006 Jan; 17(1):150-9. PubMed ID: 16319187
[TBL] [Abstract][Full Text] [Related]
20. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice.
Huang XR; Tipping PG; Shuo L; Holdsworth SR
Kidney Int; 1997 Jan; 51(1):94-103. PubMed ID: 8995722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
